Miriam Lerner M.Sc. - Co CEO, CTO

Ms. Lerner received her MSc in applied microbiology from the Hebrew University of Jerusalem. For over 20 years she has been involved in the R&D of diagnostic technologies, previously holding senior management positions in two companies from their establishment stage. She is experienced in leading project and research teams, as well as in QA Management. Miriam has co-authored several scientific publications relating to her research.

Dr. Roy Eldor, M.D.- Medical Director

Dr. Eldor is the director of the Diabetes Unit in the institute for Endocrinology, Metabolism and Hypertension, in the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and the director of the Central District Diabetes Clinic,  Leumit HMO, Israel. Endocrinologist, internist and researcher with over twenty years of clinical, academic and scientific experience. Principal Scientist in Late Stage Development- Clinical Research Diabetes & Endocrinology, Merck Research Laboratories (MRL), Rahway, NJ, USA. Recognized expert, with over 40 peer reviewed papers and book chapters and invited speaker in international meetings.

Prof. Ido Wolf - Member of the Scientific Advisory Board

Prof. Wolf specializes in research on gastrointestinal malignancies, neuroendocrine tumors and the endocrine aspects of cancer. He served as the Head of the Oncology Department at the Chaim Sheba Medical Center (2008-2012) and since 2012 he has been the Head of the Oncology Division at Tel Aviv Sourasky Medical Center.

Prof. Dedi Meiri - Member of the Scientific Advisory Board

Prof. Meiri is a lecturer, researcher and faculty member at the Technion Institute of Technology, in the fields of Cancer Biology and Cannabinoid Research. He holds a master’s degree in biochemistry, a doctorate in plant biotechnology from Tel Aviv University and a post-doctorate from the Cancer Institute in Toronto. He has published five articles on pancreatic cancer, ovarian cancer, and cancerous metastasis.

Prof.  Michal Baniyash - Inventor

Prof. Baniyash received her Ph.D. in Immunology from the Weizmann Institute of Science and is currently a lecturer and principle investigator in the Department of Immunology and Cancer Research at the Hebrew University of Jerusalem. She has more than 20 years of experience leading immunological research on the mechanisms and clinical implications of chronic inflammation and suppression of the immune system in various diseases; and has over 50 publications in prestigious medical journals and numerous inventions on biomarkers in her field.

Raphael Nir Ph.D. Co-Founder

Received his PhD in Biotechnology at  Tel-Aviv University. A scientist, entrepreneur and angel investor with over 27 years of experience commercializing recombinant cytokines and pre-clinical contract research services. He is the co-founder of two pre-clinical contract research organizations: SBH Sciences and Woodland Biosciences; and three biotechnology companies: Karyopharm Therapeutics (NASDAQ: KPTI), Galectin Sciences and Alma Bio Therapeutics

Gil Pogozelich Ph.D. - Chairman

Dr. Pogozelich is highly experienced, and for 20 years has been leading successful technology startups. Now specializes in the development, integration and commercialization of Life Science technologies, with emphasis on the field of personalized medicine. Previously specialized in the management of complex development teams in algorithms and engineering and has registered and co-registered a number of patents.